Stents. CPR. Clot-busting drugs. Those are just a few of the scientific advancements that were begun with research grants from the American Heart Association.
Five researchers funded by the American Heart Association shared information on their studies during the American Heart Association’s Research Reception at Monroe Golf Club on Thursday, March 13. The event included poster sessions and one program presentation.
“Research like the studies presented tonight build upon the American Heart Association’s century of advancing scientific investigation and transforming care for millions of heart disease and stroke patients around the world,” said Megan Vargulick, executive director of the American Heart Association in Rochester, “Since our founding more than 100 years ago, research has led the way to better treatment and prevention. Ultimately, research will lead to a cure for these leading causes of death and disability. We’re proud to be the leading nonprofit organization funding cardiovascular and cerebrovascular disease research.”
Bold investments in the American Heart Association have led to significant medical advancements including the first artificial heart valve, implantable pacemakers, cholesterol-lowering medications and techniques for CPR.
Since the 1940s, the American Heart Association has invested more than $5 billion in research, including more than $90 million in research based here in the Rochester area.
The event also celebrated the upcoming Rochester Heart Ball. The gala event will be held on May 17 at Hyatt Regency Rochester. The event will be led by co-chairmen Jason Brownlie and Gavin Brownlie of Crosby Brownlie. For more information on the Heart Ball, visit heart.org/HeartofRochester.
Provided information and photo
